I know it's been about a month since our last episode, but we're back with a super interesting talk about one of the biggest problems in medicine right now: the opioid crisis. Opioids, like hydrocodone and oxycodone, are used to treat patients with severe pain, whether it be post-surgery, cancer-rel
Publish Date: Oct 11, 2021
There are currently no snippets from The Nefarious History of the Opioid Crisis and A New Drug Platform to Address It with Dr. Mike Presti, SafeRx.
Snippets are an easy way to highlight your favorite soundbite from any piece of
audio and share with friends, or make a trailer for Medspectives
There are currently no playlists containing this audio.
Add this audio track to one of your playlists
I know it's been about a month since our last episode, but we're back with a super interesting talk about one of the biggest problems in medicine right now: the opioid crisis. Opioids, like hydrocodone and oxycodone, are used to treat patients with severe pain, whether it be post-surgery, cancer-related pain, and other similar instances. However, they trigger the release of endorphins, the brain's way of making you feel good, and this sensation can be highly addictive, leading to abuse of these drugs. Opioid abuse affects countless people across the world and costs the US hundreds of billions of dollars in costs associated with healthcare, criminal justice, and the foster system. One particularly dangerous type of abuse is consuming alcohol with opioids, which can cause respiratory distress, and ultimately death relatively quickly. While patients are advised not to take alcohol with opioids, 30-80 percent of them still do, and it is this issue that our guest Dr. Mike Presti hopes to address. Dr. Presti is a Mayo-clinic trained neurologist and CEO of SafeRx, a company using its unique alcohol-resistant opioids platform to reduce the risk of prescription opioid overdose. I don't want to give away too much in this intro, but I think this simple drug concept has the potential to revolutionize the field and prevent alcohol-related opioid abuse. It is currently in its early stages, and if you'd like to learn more or potentially be a part of the company, check it out at investinsaferx.com
Send in a voice message: https://anchor.fm/medspectives/message